As of 2025-07-07, the Relative Valuation of Kinnate Biopharma Inc (KNTE) is (51.64) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.65 USD, the upside of Kinnate Biopharma Inc based on Relative Valuation is -2048.8%.
The range of the Relative Valuation is (32.72) - (64.48) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.1x - 27.0x | 20.0x |
| Forward P/E multiples | 13.7x - 32.7x | 23.2x |
| Fair Price | (32.72) - (64.48) | (51.64) |
| Upside | -1334.6% - -2533.2% | -2048.8% |
| Date | P/E |